中国上海，2024年12月3日 – 保诺-桑迪亚，一家值得信赖的全球化合同研究、开发和生产公司（CRDMO），今日宣布任命Alan Findlater为首席商务官。
Findlater在生命科学和制药服务行业有着超过25年的高级商业领导经验，成功管理多达150专业人员组成的高效能团队，擅长管理复杂的产品和服务组合，且与安进、辉瑞和罗氏等行业内知名企业建立高价值合作伙伴关系，并在全球范围内成功推动战略增长。
Findlater拥有华威大学商学院MBA学位和斯特拉斯克莱德大学的化学荣誉学士学位。
保诺-桑迪亚首席执行官苏一名博士（Armin Spura）表示：“我们非常高兴Alan Findlater加入保诺-桑迪亚。Alan在生命科学行业的丰富且成功的经验，将助力我们进一步加强商业战略并提升市场竞争力。”
关于保诺-桑迪亚
保诺-桑迪亚，安宏资本旗下投资企业，拥有28年的历史，是一家值得信赖的全球化合同研究、开发和生产公司（CRDMO）。公司总部位于加州尔湾，在中国和美国设有7个研发生产中心，在全球拥有2000多名员工。我们专注于小分子和大分子的药物发现、开发、放大和生产服务，为生物技术和制药企业提供从早期靶点确证到商业化生产的整合服务，涵盖化学、生物学、药代动力学、原料药和成品药等多个领域。保诺-桑迪亚专注CRDMO服务，在全球化质量标准体系下运营，提供先进、快速和灵活的定制服务，以满足生物技术和制药企业的专属需求，加快新药开发进程。
更多信息，请访问公司官网http://www.bioduro-sundia.cn
BioDuro-Sundia Appoints Alan Findlater as Chief Commercial Officer to Drive Strategic Growth and Enhance Market Position
IRVINE, CALIF.,December 3 – BioDuro-Sundia, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the appointment of Alan Findlater as Chief Commercial Officer.
With over 25 years of senior commercial leadership experience in the life sciences and pharmaceutical services industry, Findlater brings a proven track record of leading high-performing teams of up to 150 professionals, managing complex product and service portfolios, building high-value partnerships with industry leaders including Amgen, Pfizer and Roche, and executing successful strategic growth initiatives on a global scale.
Findlater holds a bachelor's in chemistry from the University of Strathclyde and an MBA from Warwick Business School, both in the UK.
“We are thrilled to welcome Alan Findlater to the BioDuro-Sundia executive team,” said Dr. Armin Spura, CEO of BioDuro-Sundia. “Alan's vast experience and successful track record in the life sciences industry will be invaluable as we continue to enhance our commercial strategy, drive commercial success, and deliver innovative client-centric solutions that strengthen our market leadership.”
About BioDuro-Sundia
BioDuro-Sundia, an Advent International portfolio company, is a CRDMO with a 28-year proven track record. Headquartered in Irvine, California, USA, our global presence spans 7 sites across the United States and China, with over 2,000 employees. Specializing in both small and large molecule discovery, development, scale-up, and manufacturing, we offer fully integrated services from early drug discovery to commercial manufacturing across chemistry, biology, DMPK, drug substance, and drug product.
For more information, please visit http://www.bioduro-sundia.com
上海外高桥 | 上海张江 | 美国加州 | 无锡 | 河北 | 北京 | 蚌埠
从原料药到药品，从发现到开发，从小分子到生物制剂，保诺-桑迪亚是您的合作伙伴，可加快您的项目并提高候选药物成功的效率。
2025-06-15
26
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
收藏
登录后参与评论